Cannabotech is a next-generation CBD botanical pharmacy company, that brings to the market a unique and powerful range of preventative care CBD products, expertly created with today’s fast-paced, modern life in mind.
Our goal is to help our customers proactively and continuously supercharge their health and wellbeing. We do it by offering a wide range of innovative, scientifically based preventative-health solutions.
Our products are based on the unique M2CBD formula creating a supercharged, integrative effect on your health. The powerful combination of pharmaceutical-grade, isolated CBD and a unique blend of functional mushrooms simultaneously targets both your immune and your endocannabinoid systems, creating a supercharged effect on your health.
Also as part of our philosophy, we believe in a personalization treatment with an option of a 1:1 meeting with our professional healthcare & a DNA kit in our MyBeing program subscription (6 or 4 months).
How did you come up with the idea for the company?
In 2016 I discovered the scientific virtues of functional mushrooms during my stay in the Far East. I assembled a well-experienced and professional team from the pharmaceutical industry to create an advanced business model, with Prof. Fuad Fares & Prof Solomon Wasser, world leaders in mushroom research.
In 2018 the team realised the options of combining the mushrooms with the hemp plant and signed a partnership with Haifa University, Israel to accelerate the process to find integrative and preventative solutions focusing on these two elements.
More from Interviews
- A Chat With Cathie Hall, Chief Customer And Product Officer At IFS, On How AI Can Preserve Institutional Knowledge
- A Chat With Dr Kayode Adedapo Kolawole, Sales Director At Nagode Industries And SaaS 66 Judge
- A Chat With Dearbhail Ormond, Founder Of frendo, On Building Free Support For Endometriosis
- A Conversation With Semrush On AI Search, Brand Visibility And Spotlight 2026
- A Chat With Ollie Whiting, CEO Of La Fosse, On The Human Side Of Digital Change
- A Chat With Chris Kincade, Founder Of Starling Memory Works, On Why Your AI Doesn’t Know Your Business
- A Chat With Mark Boost, CEO And Co-founder Of Civo, On Data Sovereignty And The Case For A UK-First Cloud Strategy
- An Interview With James Murdoch, Director Of Kynekt, The UK’s Leading Equipment Protection Platform For The Construction And Trades Industry
How has the company evolved during the pandemic?
The team were in the early stages of research and creating the business infrastructure when the pandemic hit. Working from home made us more efficient in our processes – in fact, our second fundraising round, which raised over 3M€ (From a total of 10M€) was completed during the pandemic. It has only been in the last few months that we have gone back to working from the offices and in August we visited the UK and closed all our contracts & partnerships.
What can we hope to see from Cannabotech in the future?
We have just opened our first store in Westfield, White City, London, and we are aiming for three more stores in the next year. The UK is the biggest and fastest growing CBD market in Europe, which is only second to the U.S market.
In Q2 of 2022 we will be expanding our franchise into Europe and the US, whilst also launching our integrative solution (5 types of Cancer) into Israel and the U.S.
